Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Nanosonics Limited ( (AU:NAN) ) has provided an announcement.
Nanosonics Limited reported a strong performance for the first half of FY25, with a projected profit before tax of $10.9 million, significantly up from the previous year’s $4.9 million. The company also expects total revenue to rise to $93.6 million, marking an 18% increase from the previous period, driven by a substantial 20% growth in consumables and service annuity revenue streams. Despite a slight decline in gross margin, operating expenses increased by 10%, reflecting the company’s growth and operational expansion. These results underscore Nanosonics’ solid market positioning and optimistic financial outlook for the rest of the fiscal year, suggesting positive implications for stakeholders.
More about Nanosonics Limited
Nanosonics Limited is a leader in infection prevention solutions, focusing on providing innovative healthcare products and services. The company is known for its emphasis on infection prevention, with its flagship product trophon being a notable offering in this space.
YTD Price Performance: 20.32%
Average Trading Volume: 1,130
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $682.3M
For detailed information about NAN stock, go to TipRanks’ Stock Analysis page.
